MIR122, microRNA 122, 406906

N. diseases: 250; N. variants: 3
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.100 Biomarker disease BEFREE Although microRNA-29b (miRNA-29b) and microRNA-122 (miRNA-122) have great potential in treating liver fibrosis via regulating profibrotic genes in hepatic stellate cells (HSCs), it is still a challenge to achieve a HSC-targeted and meanwhile noninvasively trackable delivery of miRNAs in vivo. 30886803 2019
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.100 AlteredExpression disease BEFREE Furthermore, FoxO1 increased miR-122 and pri-miR-122 (primary miR-122) levels in HSCs in vivo, and reduced leptin-induced HSC activation and liver fibrosis in ob/ob mouse (leptin deficient) model. 29248466 2018
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.100 GeneticVariation disease BEFREE This study provides partial evidence that STF-083010 alleviated CCl<sub>4</sub>-induced liver injury and thus protected against liver fibrosis associated with hepatic miR-122. 30538632 2018
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.100 AlteredExpression disease BEFREE NEAT1 accelerates the progression of liver fibrosis via regulation of microRNA-122 and Kruppel-like factor 6. 28864835 2017
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.100 Biomarker disease BEFREE Further experiments indicated that miR-122 inhibited leptin-induced liver fibrosis in leptin-deficient mouse model. 29054053 2017
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.100 AlteredExpression disease BEFREE A lower serum miR-122 level is a useful predictor of advanced liver fibrosis in HBV-infected patients. 28475652 2017
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.100 Biomarker disease BEFREE Plasma miR-122 and miR-21 had strong correlation with degree fibrosis in HCV genotype-4 patients; consequently they can be considered as potential biomarker for early detection of hepatic fibrosis. 28642869 2017
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.100 Biomarker disease BEFREE Results demonstrate that miR-122 modification improves the therapeutic efficacy of AMSCs through exosome-mediated miR-122 communication; thus, miR-122 modification is a new potential strategy for treatment of liver fibrosis. 28544786 2017
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.100 AlteredExpression disease BEFREE Reduced expression of miR-122 in advanced fibrosis and its correlation with fibrosis stage and LS values seem to be characteristic of hepatic fibrosis of various etiologies. 26167081 2015
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.100 AlteredExpression disease BEFREE We found that miR-21 expression correlated with viral load, fibrosis and serum liver transaminase levels. miR-122 expression inversely correlated with fibrosis, liver transaminase levels and patient age. miR-21 was induced ∼twofold, and miR-122 was downregulated on infection of cultured cells with the HCV J6/JFH infectious clone, thus establishing a link to HCV. 20625373 2010